10.8 C
Munich
Friday, March 24, 2023

CATEGORY

BioPharma

CytoDyn Inc (OTCMKTS: CYDY) Steady Rise Northbound as New President Takes Control & Implements Ambitious Plans for Leronlimab (PRO 140)

CytoDyn Inc (OTCMKTS: CYDY) continues to trend higher in recent trading averaging around $1 million in dollar volume per day and still among the...

Q BioMed Inc (OTCMKTS: QBIO) Big Move as Biotech Reports US Patent for Uttroside B Expected as Pre-Clinical Testing Supports Advancing Program for Liver...

Q BioMed Inc (OTCMKTS: QBIO) is making a powerful run up the charts after the Company announced its asset; Uttroside B – is expected...

Enzolytics Inc (OTCMKTS: ENZC) On the Move as Co Files Audited Financials & Reports ITV-1 Anti-HIV Therapeutic is Safe & Non-Toxic (More on EMA...

Enzolytics Inc (OTCMKTS: ENZC) has formed a strong base over $0.04 and ontinues to trend higher on steady accumulation and not much selling. Volume...

American International Holdings Corp (OTCMKTS: AMIH) Heating Up After Big Reversal off 52 Week Lows (Spotlight on COSM ZipDoctor Acquisition)

American International Holdings Corp (OTCMKTS: AMIH) has been heating up in recent days closing up 45% on Tuesday on 45 million shares traded or...

PSYC Corporation (OTCMKTS: PSYC) Breakout Northbound on Psychedelicspotlight.com Continued Growth as Co Looks to go QB

PSYC Corporation (OTCMKTS: PSYC) is making a big move up on Monday topping 11 million shares traded and up more than 40% on the...

Anavex Life Sciences Corp (NASDAQ: AVXL) Steady Rise Up the Charts on Positive ANAVEX®2–73 (Blarcamesine) Phase 2B/3 Data as February 7 Conference Call Looms

Anavex Life Sciences Corp (NASDAQ: AVXL) is making a steady run northbound since a brief dip below $8 per share in the 2nd week...

Spotlight on Northwest Biotherapeutics, Inc., (OTCQB: NWBO) As Co Releases Important Update on Shareholders Meeting & 2023 Plans (More on Positive Top-Line Results from...

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is among the top most traded stocks on the OTCQB regularly topping 1,000 trades per day and from $1...

Skye Bioscience Inc (OTCMKTS: SKYE) Heats Up as its SBI-100 OE Phase 1 Clinical Trial to Treat Glaucoma Progresses

Skye Bioscience Inc (OTCMKTS: SKYE) has started 2023 with a bang running off 52-week lows of $0.0105 to recent highs of $0.038 per share....

A Close Look at Electromedical Technologies Inc (OTCMKTS: EMED)

Electromedical Technologies Inc (OTCMKTS: EMED) has been on the rise since reversing off $0.0056 lows in December. Recently moving back over $0.01 EMED is...

Panacea Life Sciences Holdings Inc (OTCMKTS: PLSH) Reversing Northbound as Company Announces LOI to Acquire 100% of N7 Enterprises

Panacea Life Sciences Holdings Inc (OTCMKTS: PLSH) has been on the move upwards since reversing off $0.043 lows earlier in January. The stock was...

Latest news